DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals Incorporated
USAGE: Oral
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Trikafta is designed to address the underlying genetic mutations in individuals with CF and has been shown to significantly improve lung function and overall health in many patients.
